Scribe Therapeutics’ one-time epigenetic treatment is designed to slash the adherence burden of chronic cholesterol-lowering ...

Agriculture has always evolved through better tools.

In people with type 1 diabetes, the immune system mistakenly destroys the pancreatic beta cells responsible for producing ...

California's bid to ban glow-in-the-dark rabbits and other designer pets stalls as gene-editing technology advances ...

In people with type 1 diabetes, the immune system mistakenly destroys the pancreatic beta cells responsible for producing ...

For millions of people living with high cholesterol, the routine is familiar and exhausting: a pill every morning, an ...

Researchers are testing VERVE 102, a one-time gene-editing infusion aimed at lowering LDL cholesterol by targeting PCSK9 in ...

Verve-102 uses gene editing to target PCSK9 and lower LDL cholesterol after one infusion, showing promising early results but ...

VERVE-102 cut LDL cholesterol by about 62% in an early trial, most helpful for those with family history, but more diverse ...

CRISPR/Cas9-induced DNA double-strand breaks (DSBs) are widely used for genome engineering, yet their capacity to provoke sister chromatid exchange (SCE) and associated genome instability remains ...

Every cell in the body contains essentially the same DNA, yet a brain cell behaves differently from a muscle cell or an ...